申请人:Bayer Aktiengesellschaft
公开号:US04099011A1
公开(公告)日:1978-07-04
Pyrazoles of the formula ##STR1## wherein R is hydrogen, alkyl, aryl, aralkyl, trifluoromethyl or a heterocycle; R.sup.1 is aryl or aralkyl unsubstituted or substituted by halo, trifluoromethyl, alkyl, alkoxy or nitro; or a halo-substituted alkylthio moiety; R.sup.2 is lower alkyl; phenyl; or benzyl; R.sup.3 is aryl unsubstituted or substituted by alkyl, alkenyl, alkoxy, halo, trifluoromethyl, trifluoromethoxy, mono- or di-alkylamino, nitro, cyano, carboxamido, sulphonamido or SO.sub.n -alkyl; phenyl having fused thereto a 5- to 7-membered isocyclic or heterocyclic ring, said heterocyclic ring having 1 or 2 oxygen or sulphur heteroatoms; or pyridyl; and R.sup.4 is unsubstituted or substituted carboacyl or sulphonyl; are useful for their diuretic, saluretic, antihypertensive and antithrombotic properties.
式为 ##STR1## 的吡唑类化合物,其中 R 为氢、烷基、芳基、芳基烷基、三氟甲基或杂环;R.sup.1 为芳基或芳基烷基,未取代或取代为卤素、三氟甲基、烷基、烷氧基或硝基;或卤素取代的烷硫基;R.sup.2 为较低的烷基、苯基或苄基;R.sup.3 为芳基,未取代或取代为烷基、烯基、烷氧基、卤素、三氟甲基、三氟甲氧基、单烷基或二烷基氨基、硝基、氰基、羧酰胺、磺酰胺或 SO.sub.n-烷基;苯基并有一个5-到7-成员的异环或杂环环,所述杂环具有1或2个氧或硫杂原子;或吡啶基;R.sup.4 为未取代或取代的羧基酰基或磺酰基。这些化合物具有利尿、盐利尿、降压和抗血栓作用。